Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: tnsaf who wrote (5592)	10/25/1998 1:31:00 PM
From: Izzy	Read Replies (1) \| Respond to of 6136

Jason, thank you. I would encourage all investors to read the Aug 10K and the most current one. I've been a shareholder for 3+ yrs & hadn't fully realized how this initial small biotech company has blossomed into such a major biopharm company with a terrific drug pipeline that includes extensive ongoing clinical trials. I now realize that the "AGPH Home Page" does not make mention of Thymitaq. However, the SI "profile" does and it's this area that is not current and potentially misleading to others. Everyone's input is greatly appreciated.